Pluristem Initiates Pre-Clinical Study for PLX-1, an Innovative Stem Cell Solution for Improved Engraftment During Bone Marrow Transplantation.

Business Wire › April 24, 2006

Linked as:

Extract

Pluristem Initiates Pre-Clinical Study for PLX-1, an Innovative Stem Cell Solution for Improved Engraftment During Bone Marrow Transplantation.

HAIFA, Israel -- Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy company dedicated to the commercialization of stem cell products, today announced that the Company has started an animal model study of its innovative ste...

See the full content of this document